Myelin Oligodendrocyte Glycoprotein 35-55, mouse, rat | ≥99%(HPLC) | Selleck | Others
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
Myelin Oligodendrocyte Glycoprotein Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological
Frontiers | Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
Cureus | Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series
New clinical implications of anti-myelin oligodendrocyte glycoprotein antibodies in children with CNS demyelinating diseases - Multiple Sclerosis and Related Disorders
Distinction and Temporal Stability of Conformational Epitopes on Myelin Oligodendrocyte Glycoprotein Recognized by Patients with Different Inflammatory Central Nervous System Diseases | The Journal of Immunology
Neuromyelitis optica spectrum disorders | RCP Journals
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis - ScienceDirect
Figure 3 from Autoantibodies to myelin oligodendrocyte glycoprotein (MOG) in patients with demyelinating diseases of the central nervous system (CNS) | Semantic Scholar
Figure Model contrasting the potential role of antibodies to myelin... | Download Scientific Diagram
Pathology of myelin oligodendrocyte glycoprotein antibody–associated disease - Misu - 2021 - Clinical and Experimental Neuroimmunology - Wiley Online Library
E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders - European Journal of Paediatric Neurology
MOG antibody demyelination | Great Ormond Street Hospital
Myelin oligodendrocyte glycoprotein revisited—sensitive detection of MOG-specific T-cells in multiple sclerosis - ScienceDirect
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis | PNAS
![Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease [MOG-AD]](https://image.slidesharecdn.com/myelinoligodendrocyteglycoproteinmogantibodydisease0920-200920055159/85/myelin-oligodendrocyte-glycoprotein-mog-antibody-disease-mogad-2-320.jpg?cb=1662487688 "Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease [MOG-AD]")
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease [MOG-AD]
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis an
Figure 4 | Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review | SpringerLink
Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
MOG - "Myelin Oligodendrocyte Glycoprotein" by AcronymsAndSlang.com
Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease - ScienceDirect
Figure 4 Neuropathology of MOG and AQP4 antibody–associated demyelinating lesions in the brain The biopsy specimen revealed a small actively demyelinating. - ppt download
